Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.2 | 0.03 |
mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.03 |
mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.18 | 0.09 |
mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.17 | 0.06 |
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.05 |
mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.06 |
mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.07 |
mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0002 |
mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.15 | 0.09 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.007 |